Aadi Bioscience Inc expected to post a loss of 46 cents a share - Earnings Preview
04/11/2024 15:42
* Aadi Bioscience Inc AADI.OQ AADI.O is expected to show
a
rise in quarterly revenue when it reports results on November 6
for the period ending September 30 2024
* The Pacific Palisades California-based company is
expected to
report a 10.7% increase in revenue to $6.596 million from $5.96
million a year ago, according to the mean estimate from 4
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Aadi Bioscience Inc is
for a
loss of 46 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Aadi
Bioscience
Inc is 1.63, below its last closing price of $1.99.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 -0.69 -0.69 -0.54 Beat 21.7
Mar. 31 2024 -0.63 -0.64 -0.68 Missed -5.8
Jan. 1 0001 -0.65 -0.60 Beat 7.4
Sep. 30 2023 -0.72 -0.72 -0.60 Beat 17.1
Jun. -0.61 -0.62 -0.67 Missed -7.7
30 2023
Jan. 1 0001 -0.58 -0.58 -0.57 Beat 2.4
Dec. 31 2022 -0.71 -0.52 Beat 26.8
Sep. 30 2022 -0.74 -0.74 -0.68 Beat 8.4
This summary was machine generated November 4 at 15:42 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)